Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20835341 | 0.91 | ALDH1A1 (0.40) | ALDH1A1MAPK1LMNACA2CYP3A4 | |
| SCHEMBL28974096 | 0.91 | ALDH1A1 (0.34) | ALDH1A1MAPK1PRSS1PRSS2PRSS3 | |
| SCHEMBL19834895 | 0.90 | ALDH1A1 (0.44) | ALDH1A1MAPK1LMNACA2CYP3A4 | |
| SCHEMBL5549692 | 0.86 | EPHX2 (0.31) | — | |
| SCHEMBL76644 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MAPK1LMNACA2CYP3A4 | |
| SCHEMBL29496845 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MAPK1LMNACA2CYP3A4 | |
| SCHEMBL31631277 | 0.83 | ALDH1A1 (0.36) | ALDH1A1MAPK1LMNACA2CYP3A4 | |
| SCHEMBL6832924 | 0.83 | RXFP1 (0.34) | ALDH1A1 | |
| SCHEMBL6245434 | 0.83 | — | — | |
| SCHEMBL7072419 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1LMNACA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 575 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522534-B2 | Self-healing optical fibers and the compositions used to create the same | COVESTRO (NETHERLANDS) B.V. (NL) | 2026-01-13 | — | — | US | disclosed |
| US-12491704-B2 | Multi-layered optical devices | COVESTRO (NETHERLANDS) B.V. (NL) | 2025-12-09 | — | — | US | disclosed |
| US-20250346751-A1 | ACRYLONITRILE STYRENE ACRYLATE COPOLYMER COMPOSITION WITH IMPROVED UV RESISTANCE | INEOS STYROLUTION GROUP GMBH (DE) | 2025-11-13 | — | — | US | disclosed |
| EP-3941970-B1 | UV CURABLE COMPOSITIONS FOR DIRT PICK-UP RESISTANCE | BASF SE (DE) | 2025-10-15 | — | — | EP | disclosed |
| US-12426670-B2 | Midsole structure of an article of footwear including mesh | NIKE, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4008210-B1 | A KNIT TEXTILE | NIKE INNOVATE CV (US) | 2025-08-27 | — | — | EP | disclosed |
| US-20250251531-A1 | LOW-VOLATILITY RADIATION CURABLE COMPOSITIONS FOR COATING OPTICAL FIBERS | COVESTRO LLC | 2025-08-07 | — | — | US | disclosed |
| US-12342902-B2 | Footwear sole structure having a composite element and methods for manufacturing same | NIKE, INC. (US) | 2025-07-01 | — | — | US | disclosed |
| EP-3538699-B1 | KNIT ARTICLES AND PROCESSES FOR MAKING THE SAME | NIKE INNOVATE CV (US) | 2025-05-07 | — | — | EP | disclosed |
| EP-3841166-B2 | STABILIZED ROTOMOLDED POLYOLEFIN | BASF SE (DE) | 2025-05-07 | — | — | EP | disclosed |
| US-20020106413-A1 | Mixtures of phenolic and inorganic materials with antimicrobial activity | CIBA CORPORATION | 2002-08-08 | — | — | US | disclosed |
| US-20020086924-A1 | Stabilized gamma irradiated polyolefins | CIBA SPECIALTY CHEMICALS CORP. | 2002-07-04 | — | — | US | disclosed |
| EP-1171890-A1 | STABILIZED TELECOMMUNICATION CABLE INSULATION COMPOSITION | Ciba SC Holding AG (CH) | 2002-01-16 | — | — | EP | disclosed |
| US-20020002242-A1 | Hyperbranched amphiphilic polymeric additives and polymer compositions with increased surface energy | CIBA SPECIALTY CHEMICALS CORP. | 2002-01-03 | — | — | US | disclosed |
| US-20010047046-A1 | Polyolefin film compositions with permanent antifog properties | TECHMER PM, LLC | 2001-11-29 | — | — | US | disclosed |
| EP-1152027-A1 | Polyolefin film compositions with permanent antifog properties | Ciba SC Holding AG (CH) | 2001-11-07 | — | — | EP | disclosed |
| EP-1106627-A1 | Novel phosphine oxide photoinitiator systems and curable compositions with low color | Ciba SC Holding AG (CH) | 2001-06-13 | — | — | EP | disclosed |
| US-6228495-B1 | MIXTURE OF POLYOLEFIN AND ANTIOXIDANT | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-05-08 | — | — | US | disclosed |
| WO-2000058975-A1 | STABILIZED TELECOMMUNICATION CABLE INSULATION COMPOSITION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-10-05 | — | — | WO | disclosed |
| EP-1038912-A2 | High molecular weight hindered hydrocarbyloxyamine stabilizers | Ciba SC Holding AG (CH) | 2000-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020106413-A1 | Mixtures of phenolic and inorganic materials with antimicrobial activity | CUTA, PUF60, TYR | ALDH1A1 2607/4885MAPK1 255/4885LMNA 1657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.